Selective cell therapy for the treatment of renal failure

Details for Australian Patent Application No. 2008262333 (hide)

Owner Wake Forest University Health Sciences

Inventors Yoo, James; Atala, Anthony

Agent Watermark

Pub. Number AU-A-2008262333

PCT Pub. Number WO2008/153970

Priority 60/942,716 08.06.07 US

Filing date 6 June 2008

Wipo publication date 18 December 2008

International Classifications

C07K 14/505 (2006.01) Peptides having more than 20 amino acids

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2008/153970 Priority application(s): WO2008/153970

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008262341-Real property information management, retention and transferal system and methods for using same

2008262331-Inkjet gene printing